Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $48.86 --0%
Rating Summary:
6 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Rating Summary:
6 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- PureTech Announces Annual Results for Year Ended December 31, 2023
- Chipotle Mexican Grill (CMG) PT Raised to $3,400 at KeyBanc
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
